NM_002474.3:c.3651+5_3651+11delTGCTTTTinsG
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP6
The NM_002474.3(MYH11):c.3651+5_3651+11delTGCTTTTinsG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002474.3 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- lissencephaly 4Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- hydranencephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- microlissencephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- NDE1-related microhydranencephalyInheritance: Unknown, AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002474.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH11 | NM_002474.3 | MANE Select | c.3651+5_3651+11delTGCTTTTinsG | splice_region intron | N/A | NP_002465.1 | |||
| MYH11 | NM_001040113.2 | MANE Plus Clinical | c.3672+5_3672+11delTGCTTTTinsG | splice_region intron | N/A | NP_001035202.1 | |||
| MYH11 | NM_001040114.2 | c.3672+5_3672+11delTGCTTTTinsG | splice_region intron | N/A | NP_001035203.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH11 | ENST00000300036.6 | TSL:1 MANE Select | c.3651+5_3651+11delTGCTTTTinsG | splice_region intron | N/A | ENSP00000300036.5 | |||
| MYH11 | ENST00000452625.7 | TSL:1 MANE Plus Clinical | c.3672+5_3672+11delTGCTTTTinsG | splice_region intron | N/A | ENSP00000407821.2 | |||
| MYH11 | ENST00000396324.7 | TSL:1 | c.3672+5_3672+11delTGCTTTTinsG | splice_region intron | N/A | ENSP00000379616.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Benign:3
The variant is found in TAAD panel(s).
Aortic aneurysm, familial thoracic 4 Uncertain:1
Cardiovascular phenotype Uncertain:1
There is insufficient or conflicting evidence for classification of this alteration.
not specified Benign:1
Variant summary: MYH11 c.3672+5_3672+11delinsG alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of approximately 0.0017 in 282664 control chromosomes, predominantly at a frequency of 0.019 within the African or African-American subpopulation in the gnomAD database, including 15 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is much higher than the estimated maximal expected allele frequency for a pathogenic variant in MYH11 causing Aortopathy phenotype (1.3e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.3672+5_3672+11delinsG has been reported in the literature in at least one individual affected with thoracic aortic aneurysm (e.g. Bee_2012). This report does not provide unequivocal conclusions about association of the variant with Aortopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, citing the variant as benign/ likely benign (n=3) and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as benign.
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at